RONKE
ABOUT RONKE AI
Remote
Observation of
Need,
Knowledge &
Evaluation

Founded in Manchester in 2025, RONKE AI Ltd exists for one reason: no elderly patient should be excluded from healthcare innovation because they can't use an app.

WHO WE BUILD FOR

We design for Margaret first.

Margaret is 78. She lives alone with a basic mobile phone. She can't use health apps, but she can answer her phone. RONKE was built for Margaret, not despite her limitations.

Our design rule is simple: if it works for an 85-year-old with arthritis and hearing difficulties, it works for everyone.

HEALTHCARE EQUITY
Technology should serve all patients, not just the tech-savvy. Voice-first design reaches 95%+ of patients: no smartphone, no app, no setup.
CLINICAL EXCELLENCE
Evidence-based medicine, clinical advisory oversight, academic partnership, published outcomes. Patient safety is non-negotiable.
INNOVATION THROUGH APPLICATION
We don't reinvent voice AI, we apply proven technology where it creates patient value. Execution over invention, always.
THE TEAM

Engineers, clinicians and researchers, accountable by name.

SO
Stephen Owojori
FOUNDER & AI ENGINEER
Digital health entrepreneur. NHS market strategy and health technology commercialisation.
AA
Ayokunmi Adejimiroye
PRODUCT MANAGER
Product strategy and delivery, ensuring RONKE AI meets real NHS clinical workflow requirements.
MA
Dr. Moslem Abdelghafar
CLINICAL ADVISOR & CLINICAL SAFETY OFFICER
Cardiothoracic Surgeon. Member, SCTS Innovation Committee. International publications in cardiac surgery and digital health.
RM
Dr. Reyhane Moradihaghighat
AI RESEARCH LEAD
PhD candidate, Manchester Metropolitan University. Research in AI-based diagnostics for cardiac conditions.
THE NEXT DECADE

From proving it works, to changing what "standard of care" means.

2025–2027 · PIONEER
Prove voice-first works
Clinical validation with NHS partners. Establish RONKE as the standard for post-discharge heart failure monitoring in the UK.
2028–2030 · LEADER
Beyond heart failure
COPD, diabetes, kidney disease. International expansion. 100,000+ patients monitored.
2031–2035 · TRANSFORM
A new standard of care
Voice-first monitoring becomes how healthcare listens to the elderly, millions of patients, the digital exclusion gap closed systemically.
MANCHESTER, UNITED KINGDOM
"A future where no elderly patient is excluded from healthcare innovation, and every discharged heart failure patient receives the monitoring they need to stay healthy at home."
— Our vision, on every wall of the company
Founded2025
HeadquartersManchester, UK
Academic partnerManchester Met
RegisteredRONKE AI Ltd · No. 16865109
NOW · INNOVATE UK BIOMEDICAL CATALYST
Applying for funding to run a clinical pilot with NHS trust partners.
We are seeking letters of support from NHS trusts who recognise the clinical need, not a commitment, just a willingness to explore participation in a funded pilot.
Support the application →

Help us build healthcare that answers when Margaret calls.

Work with us Investor enquiry
RONKE © 2026 RONKE AI Ltd · Reg. No. 16865109 · Manchester, UK
Home Technology Clinical evidence hello@ronkeai.com